Shipment term

First shipment of Paxlovid, an antiviral drug for COVID-19, arrives in Ontario

TORONTO — Health Minister Christine Elliott said the first shipment of antiviral treatment for COVID-19 has arrived in Ontario.

The oral antiviral drug Paxlovid is intended to protect against hospitalization and death.

Elliott previously said Ontario was due to receive 10,000 treatments in January, and she says today the province has secured an additional 400 doses for northern First Nations communities.

Read more:

Pfizer’s Paxlovid pill does not replace COVID-19 vaccine, officials say

The drug is initially prioritized for adults most at risk, including immunocompromised patients.

Ontario today reports 4,114 people hospitalized with COVID-19 and 590 people in intensive care units.

That’s up from the 4,061 hospitalizations reported the previous day and a slightly lower number of people in intensive care, up from 594.

The story continues under the ad

The province is also reporting 62 other deaths related to COVID-19.

Read more:

4,114 people in Ontario hospitals with COVID, 590 in intensive care

Ontario is reporting 7,165 new cases of COVID-19, though Public Health Ontario said the number is likely higher due to a current policy limiting access to testing.

More than half of the province’s long-term care homes have active outbreaks of COVID-19.

About 88% of Ontarians aged five and older have received at least one dose of a COVID-19 vaccine, and 83% have received two.

See link »

© 2022 The Canadian Press